Feng, Yuemin
Wu, Hao
Huang, Daniel Q.
Xu, Chenghui
Zheng, Hang
Maeda, Mayumi
Zhao, Xinya
Wang, Le
Xiao, Feng
Lv, Huanran
Liu, Tiantian
Qi, Jianni
Li, Jie
Zhong, Ning
Wang, Chuanxi
Feng, Hong
Liang, Bo
Ren, Wanhua
Qin, Chengyong
Nguyen, Mindie H.
Zhu, Qiang http://orcid.org/0000-0002-5843-9724
Funding for this research was provided by:
National Natural Science Foundation of China (81570551, 81770607)
Key Research Project of Shandong Province (2016GSF201008)
Article History
Received: 16 January 2020
Revised: 22 April 2020
Accepted: 27 May 2020
First Online: 11 June 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is Prof. Qiang Zhu.
: Dr. Mindie H. Nguyen has received research support from the National Cancer Institute, B.K. Kee Foundation, Gilead, Pfizer, and has served as consultant and/or advisory board member for Exact Sciences, Laboratory of Advanced Medicine, Gilead, Eisai, Bayer, Spring Bank, and Novartis.All other authors hereby declare that there is no potential or actual personal, financial, or political interest related to this study.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: • retrospective• prognostic study• multicenter study